Filtros : "CELULOSE" "FCF004" Limpar

Filtros



Refine with date range


  • Source: Enzyme and Microbial Technology. Unidades: EACH, FOB, FCF, IQ

    Subjects: ENZIMAS, MATERIAIS NANOESTRUTURADOS, CELULOSE, BAGAÇOS, CANA-DE-AÇÚCAR

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BRITES, Mariana de Melo et al. Bromelain immobilization in cellulose triacetate nanofiber membranes from sugarcane bagasse by electrospinning technique. Enzyme and Microbial Technology, v. 132, n. Ja 2020, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.enzmictec.2019.109384. Acesso em: 07 set. 2024.
    • APA

      Brites, M. de M., Cerón, A. A., Costa, S. M. da, Oliveira, R. C. de, Ferraz, H. G., Catalani, L. H., & Costa, S. A. da. (2020). Bromelain immobilization in cellulose triacetate nanofiber membranes from sugarcane bagasse by electrospinning technique. Enzyme and Microbial Technology, 132( Ja 2020). doi:10.1016/j.enzmictec.2019.109384
    • NLM

      Brites M de M, Cerón AA, Costa SM da, Oliveira RC de, Ferraz HG, Catalani LH, Costa SA da. Bromelain immobilization in cellulose triacetate nanofiber membranes from sugarcane bagasse by electrospinning technique [Internet]. Enzyme and Microbial Technology. 2020 ; 132( Ja 2020):[citado 2024 set. 07 ] Available from: https://doi.org/10.1016/j.enzmictec.2019.109384
    • Vancouver

      Brites M de M, Cerón AA, Costa SM da, Oliveira RC de, Ferraz HG, Catalani LH, Costa SA da. Bromelain immobilization in cellulose triacetate nanofiber membranes from sugarcane bagasse by electrospinning technique [Internet]. Enzyme and Microbial Technology. 2020 ; 132( Ja 2020):[citado 2024 set. 07 ] Available from: https://doi.org/10.1016/j.enzmictec.2019.109384
  • Source: Drug Development and Industrial Pharmacy. Unidade: FCF

    Subjects: ENZIMAS, CELULOSE, PROTEÍNAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      VARCA, Gustavo Henrique Costa e LOPES, Patricia S e FERRAZ, Humberto Gomes. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach. Drug Development and Industrial Pharmacy, v. 41, n. 3, p. 430-435, 2015Tradução . . Disponível em: https://doi.org/10.3109/03639045.2013.877481. Acesso em: 07 set. 2024.
    • APA

      Varca, G. H. C., Lopes, P. S., & Ferraz, H. G. (2015). Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach. Drug Development and Industrial Pharmacy, 41( 3), 430-435. doi:10.3109/03639045.2013.877481
    • NLM

      Varca GHC, Lopes PS, Ferraz HG. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 3): 430-435.[citado 2024 set. 07 ] Available from: https://doi.org/10.3109/03639045.2013.877481
    • Vancouver

      Varca GHC, Lopes PS, Ferraz HG. Development of papain containing pellets produced by extrusion-spheronization: an operational stage approach [Internet]. Drug Development and Industrial Pharmacy. 2015 ; 41( 3): 430-435.[citado 2024 set. 07 ] Available from: https://doi.org/10.3109/03639045.2013.877481
  • Source: Pharmaceutical Development and Technology. Unidades: EP, FCF

    Subjects: COMPRIMIDOS, CELULOSE, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DUQUE, Marcelo Dutra et al. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, v. 18, n. 5, p. 1247-1254, 2013Tradução . . Disponível em: https://doi.org/10.3109/10837450.2012.693508. Acesso em: 07 set. 2024.
    • APA

      Duque, M. D., Kreidel, R. N., Taqueda, M. E. S., Baby, A. R., Kaneko, T. M., Velasco, M. V. R., & Consiglieri, V. O. (2013). Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design. Pharmaceutical Development and Technology, 18( 5), 1247-1254. doi:10.3109/10837450.2012.693508
    • NLM

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 set. 07 ] Available from: https://doi.org/10.3109/10837450.2012.693508
    • Vancouver

      Duque MD, Kreidel RN, Taqueda MES, Baby AR, Kaneko TM, Velasco MVR, Consiglieri VO. Optimization of primaquine diphosphate tablet formulation for controlled drug release using the mixture experimental design [Internet]. Pharmaceutical Development and Technology. 2013 ; 18( 5): 1247-1254.[citado 2024 set. 07 ] Available from: https://doi.org/10.3109/10837450.2012.693508

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024